NCT00237965
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
Not specified
Clinical trial condition
Melanoma
Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.
2,208 public trials
376 recruiting studies
Melanoma trial results
Completed
Ultrasound Biomicroscopy - Apoptosis
NCT00188370
- Conditions
- Carcinoma, Carcinoma, Basal Cell, Hemic and Lymphatic Diseases, +20 more
- Locations
-
- Princess Margaret Hospital Toronto, Ontario, Canada
NCT00055562
- Conditions
- Melanoma, Neoplasm Metastasis, Neoplasms, +13 more
- Locations
-
- University of Arizona Cancer Center Tucson, Arizona, United States
- University of Southern California Norris Cancer Center Los Angeles, California, United States
- UCLA Los Angeles, California, United States
- St. Francis Memorial Hospital San Francisco, California, United States
NCT00041808
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +49 more
- Locations
-
- Scripps Stevens Cancer Division San Diego, California, United States
- UCSF Cancer Center San Francisco, California, United States
- Scott and White Clinic Temple, Texas, United States
- Frankfurt Universtiy Frankfurt, Germany
Active, Not Recruiting
A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma
NCT04708418
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Melanoma of Unknown Primary, +15 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
Active, Not Recruiting
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
NCT02224781
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma, +14 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Active, Not Recruiting
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
NCT02506153
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma, +18 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- Virginia G Piper Cancer Care-Del Camino Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
Active, Not Recruiting
Zr89 + PET Companion Trial
NCT05279027
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- Perleman Center for Advanced Medicine Philadelphia, Pennsylvania, United States
Active, Not Recruiting
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
NCT01366144
- Conditions
- Adnexal Diseases, Breast Carcinoma, Breast Diseases, +70 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- City of Hope South Pasadena South Pasadena, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
Active, Not Recruiting
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
NCT02339571
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Kingman Regional Medical Center Kingman, Arizona, United States
- CARTI Cancer Center Little Rock, Arkansas, United States
- John L McClellan Memorial Veterans Hospital Little Rock, Arkansas, United States